The AKT1 Gene Cowden Syndrome Type 6 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the AKT1 gene, which are associated with Cowden Syndrome Type 6. This syndrome is a rare genetic disorder characterized by multiple, noncancerous tumor-like growths called hamartomas and an increased risk of developing certain cancers, including breast, thyroid, and endometrial cancer. The AKT1 gene plays a crucial role in cell growth and survival, and mutations in this gene can lead to abnormal cell proliferation and tumor development.
The test is crucial for individuals with a family history of Cowden Syndrome or related symptoms, as early detection and management can significantly reduce the risk of cancer and improve quality of life. The testing process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the AKT1 gene.
Priced at 4400 AED, the test is a valuable investment in personal health, offering essential information that can guide preventive measures, surveillance, and treatment options for individuals at risk of Cowden Syndrome Type 6. DNA Labs UAE provides this comprehensive genetic testing service, employing state-of-the-art technology and expertise to ensure accurate and reliable results.
The ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ATR gene, which are associated with an increased risk of developing cutaneous telangiectasia and various forms of cancer. This test is particularly important for individuals with a family history of these conditions, as it can provide crucial information regarding their genetic predisposition to these diseases.
Cutaneous telangiectasia refers to the visible dilation of small blood vessels near the skin's surface, which can be an indicator of underlying genetic conditions, including those that predispose individuals to cancer. The ATR gene plays a significant role in DNA repair and cell cycle regulation; mutations in this gene can compromise the body's ability to repair DNA damage, leading to an increased risk of cancer.
The test is conducted using a sample of the patient's blood or saliva, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. The process involves examining the genetic material for specific mutations in the ATR gene that are known to contribute to the development of cutaneous telangiectasia and cancer syndrome.
The cost of the ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test at DNA Labs UAE is 4400 AED. While the test may represent a significant investment, it offers invaluable insights into an individual's genetic health, potentially guiding preventive measures and personalized treatment strategies to mitigate the risk of developing associated conditions.
The "CYLD Gene Cylindromatosis Familial Genetic Test" is a specialized diagnostic procedure aimed at detecting mutations in the CYLD gene, which is known to cause cylindromatosis. Cylindromatosis is a rare genetic condition characterized by the development of multiple benign tumors, primarily affecting the skin. These tumors, known as cylindromas, typically arise in areas such as the scalp, face, and neck. The condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
This genetic test is crucial for families with a history of cylindromatosis, as it helps in identifying individuals who carry the genetic mutation. Early identification of carriers allows for timely surveillance and management of the condition, potentially preventing or minimizing the development of skin tumors. Moreover, the test can provide essential information for affected families regarding the risk of passing the condition to future generations.
Conducted at DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The laboratory then analyzes the CYLD gene for specific mutations known to cause cylindromatosis. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results accurately.
Given the rarity of cylindromatosis and the importance of genetic counseling, individuals considering this test are often advised to consult with a genetic counselor or a specialist in genetic diseases. This professional guidance ensures that individuals and families fully understand the implications of the test results and the condition itself.
The APC Gene Desmoid Disease Hereditary Genetic Test is a specialized diagnostic examination conducted to identify mutations in the APC gene, which are linked to the development of desmoid tumors and associated hereditary conditions. Desmoid tumors, also known as desmoid-type fibromatoses, are rare, non-cancerous growths that arise in the connective tissue of the body. These tumors can occur sporadically or as part of familial adenomatous polyposis (FAP), a hereditary colorectal cancer syndrome caused by mutations in the APC gene.
This genetic test is crucial for individuals with a family history of FAP or desmoid tumors, as it helps in the early detection and management of the condition. By analyzing the DNA, the test seeks to identify specific mutations in the APC gene that increase the risk of developing desmoid tumors and other related conditions. Early identification of at-risk individuals allows for timely surveillance and intervention, potentially reducing the morbidity associated with these tumors.
The APC Gene Desmoid Disease Hereditary Genetic Test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect and interpret genetic mutations. This test represents a critical step forward in personalized medicine, offering individuals at risk a chance to take proactive measures in managing their health and preventing the severe outcomes associated with desmoid tumors and familial adenomatous polyposis.
The EGFR Gene EGFR Selective Sequencing of Exons 18-21 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations within exons 18 to 21 of the EGFR gene. This test is crucial for patients with certain types of cancer, such as non-small cell lung cancer (NSCLC), as mutations in these specific exons can influence treatment decisions and predict responsiveness to targeted therapies. By sequencing these exons, healthcare providers can tailor treatment plans to the genetic profile of the tumor, potentially improving patient outcomes.
The test is conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing services. With a focus on precision and accuracy, DNA Labs UAE utilizes state-of-the-art sequencing technologies to ensure reliable results. The cost of the EGFR Gene EGFR Selective Sequencing of Exons 18-21 Genetic Test is set at 4400 AED, reflecting the comprehensive analysis and detailed insights it provides into the genetic alterations that may drive cancer progression and response to therapy. This test represents a critical step in the personalized medicine approach, offering hope for more effective and targeted cancer treatments.
The MSH6 gene is a critical component in the DNA mismatch repair system, which helps maintain the integrity of genetic information. Mutations in the MSH6 gene are associated with an increased risk of developing endometrial cancer, among other cancers, as part of Lynch syndrome, a hereditary condition. Recognizing the significance of early detection in managing and reducing the risk of cancer, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the MSH6 gene that are linked to familial endometrial cancer.
This genetic test is a powerful tool for individuals with a family history of endometrial cancer or Lynch syndrome, providing them with crucial information regarding their genetic predisposition to the disease. By understanding their risk, individuals can make informed decisions about their health, including taking preventive measures or undergoing more frequent screenings to catch and treat cancer at an early stage, if it develops.
The test is conducted with a high degree of accuracy and confidentiality at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the MSH6 gene endometrial cancer familial-related genetic test is 4400 AED. This investment in one's health provides invaluable insights, empowering individuals and their healthcare providers to tailor a personalized approach to cancer prevention and early detection, significantly impacting their overall well-being and life expectancy.
The APC Gene Familial Adenomatous Polyposis Coli Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the APC gene, which are linked to Familial Adenomatous Polyposis (FAP). FAP is an inherited condition characterized by the early onset of hundreds to thousands of polyps in the colon and rectum, significantly increasing the risk of colorectal cancer if left untreated. Early detection through genetic testing is crucial for managing and mitigating the risks associated with this condition.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics, offering a comprehensive range of genetic testing services. For individuals with a family history of FAP or early-onset colorectal cancer, this test provides essential information for making informed decisions about their health management and surveillance strategies.
The cost of the APC Gene Familial Adenomatous Polyposis Coli Genetic Test at DNA Labs UAE is 4400 AED. This investment can be invaluable for at-risk individuals, providing them with the opportunity for early intervention and potentially life-saving preventive measures. It is advisable for anyone considering this test to consult with a healthcare professional or a genetic counselor to fully understand its implications and how best to proceed based on the results.
The MUTYH Gene Familial Adenomatous Polyposis Type 2 Genetic Test is a comprehensive diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the MUTYH gene that are associated with Type 2 Familial Adenomatous Polyposis (FAP2), also known as MUTYH-Associated Polyposis (MAP). This condition is an autosomal recessive hereditary cancer syndrome, characterized by the development of multiple adenomatous polyps in the colon and rectum, which have a high potential to progress to colorectal cancer if not identified and managed appropriately.
The genetic test involves analyzing the patient's DNA to detect mutations in both copies of the MUTYH gene, which are necessary for the manifestation of the disease. It is a crucial tool for individuals with a family history of FAP2, or those who have symptoms suggestive of colorectal polyps, as early detection can significantly influence management and prevention strategies, including surveillance and prophylactic surgeries.
Offered at a cost of 4400 AED, the test at DNA Labs UAE represents a significant investment in personal health, providing valuable insights that can aid in the early detection and prevention of colorectal cancer associated with MUTYH mutations. The test is conducted in a state-of-the-art facility, ensuring accurate and reliable results that can guide patients and their healthcare providers in making informed decisions about their health and treatment options.
The NTHL1 Gene Familial Adenomatous Polyposis Type 3 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the NTHL1 gene that are associated with the development of Familial Adenomatous Polyposis Type 3 (FAP3). This condition is a rare, inherited disorder characterized by the early onset of hundreds to thousands of polyps in the colon and rectum, significantly increasing the risk of colorectal cancer. Early detection through genetic testing can provide crucial information for managing and mitigating these risks through surveillance and preventive measures. The test is priced at 4400 AED and is conducted with high precision and accuracy, ensuring reliable results for patients seeking to understand their genetic predisposition to this condition.
The "MSH3 Gene Familial Adenomatous Polyposis Type 4 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the MSH3 gene, which are linked to Familial Adenomatous Polyposis Type 4 (FAP4). This condition is a subtype of colorectal cancer syndrome characterized by the development of hundreds to thousands of benign polyps in the colon and rectum during adolescence or early adulthood, which may become malignant if not treated.
The test is crucial for individuals with a family history of FAP4, as it can help in early detection and management of the condition, significantly reducing the risk of colorectal cancer. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the MSH3 gene.
Offered by DNA Labs UAE, a leading facility in genetic testing and personalized medicine, the test is priced at 4400 AED. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of the test results, providing a crucial tool for individuals and families at risk of FAP4 to make informed decisions about their health and preventive care strategies.
